What Researchers Did
Researchers investigated hyperbaric oxygen therapy in two patients with intractable livedoid vasculopathy that was resistant to multiple prior treatments.
What They Found
In both patients, hyperbaric oxygen therapy led to rapid healing of chronic ulcers and simultaneous resolution of disturbing wound pain. This was reported as the first successful trial of HBO therapy for livedoid vasculopathy, suggesting it as a promising new treatment.
What This Means for Canadian Patients
For Canadian patients suffering from intractable livedoid vasculopathy, hyperbaric oxygen therapy could potentially offer a new and effective treatment option for chronic ulcers and pain. This may improve quality of life for those who have not responded to conventional therapies.
Canadian Relevance
This study has no direct Canadian connection as it was conducted by researchers outside of Canada.
Study Limitations
A significant limitation of this study is the very small sample size of only two patients.